Characteristics | SGA | AGA | LGA | P |
---|---|---|---|---|
(n = 214) | (n = 4828) | (n = 256) | ||
Maternal characteristics | ||||
Age (years) | 29 (26–33) | 30 (26–33) | 31 (28–34)** | < 0.001 |
Predelivery weight (kg) | 64 (59–72)** | 68 (63–74) | 74 (69–80)** | < 0.001 |
Height (cm) | 158 (155–160)** | 160 (157–163) | 160 (158–164)** | < 0.001 |
BMI | 25.8 (23.6–28.7)** | 26.6 (24.8–28.9) | 28.8 (26.6–30.7)** | < 0.001 |
The number of pregnancy | 2 (1–3) | 2 (1–3) | 2 (1–4)** | 0.014 |
The number of delivery | 0 (0–1) | 0 (0–1) | 1 (0–1)* | 0.004 |
Newborn information | ||||
Baby gender | ||||
Boy | 85 (39.7%)** | 2520 (52.2%) | 183 (71.5%)** | < 0.001 |
Girl | 129 (60.3%) | 2308 (47.8%) | 73 (28.5%) | |
Gestational age at birth (weeks) | 37 (37–38)** | 38 (37–39) | 39 (39–40)** | < 0.001 |
Premature infant (33–36 weeks) | 45 (21.0%)** | 418 (8.7%) | 1 (0.4%)** | < 0.001 |
The birth weight of the baby | 2355 (2195–2440)** | 3250 (2990–3510) | 4160 (4070–4300)** | < 0.001 |
Neonatal asphyxia | 0 (0%) | 15 (0.3%) | 1 (0.4%) | 0.921 |
The delivery information | ||||
Scarred uterus | 27 (12.6%) | 756 (15.7%) | 47 (18.4%) | 0.233 |
Caesarean section | 90 (42.1%)** | 1362 (28.2%) | 95 (37.1%)** | < 0.001 |
Colpoperineal laceration | 71 (33.1%)** | 2449 (50.8%) | 102 (39.9%)** | < 0.001 |
Grade I vaginal laceration | 60 (28.0%)* | 1760 (36.5%) | 58 (22.7%)** | < 0.001 |
Grade II vaginal laceration | 11 (5.1%)** | 689 (14.3%) | 44 (17.2%) | < 0.001 |
Fetal distress in uterus | 29 (13.6%) | 554 (11.5%) | 26 (10.2%) | 0.511 |
Low forceps delivery | 5 (2.3%) | 249 (5.2%) | 18 (7.0%) | 0.069 |
Diseases of pregnancy | ||||
vaginal inflammation | 25 (11.7%) | 559 (11.6%) | 36 (14.1%) | 0.484 |
Bacterial vaginosis | 6 (2.8%) | 111 (2.3%) | 15 (5.9%)** | < 0.001 |
Candida vaginosis | 20 (9.3%) | 310 (6.4%) | 18 (7.0%) | 0.229 |
Streptococcus lactis vaginitis | 2 (0.9%)* | 201 (4.2%) | 14 (5.5%) | 0.035 |
Trichomonas vaginitis | 1 (0.5%) | 6 (0.1%) | 1 (0.4%) | 0.269 |
Gestational diabetes mellitus | 46 (21.5%) | 1088 (22.5%) | 86 (33.6%)** | < 0.001 |
Hypertension | 19 (8.9%)** | 189 (3.9%) | 8 (3.1%) | < 0.001 |
Pregnancy hypertension | 12 (5.6%) | 168 (3.5%) | 6 (2.3%) | 0.148 |
Chronic hypertension | 7 (3.3%)** | 21 (0.4%) | 2 (0.8%) | < 0.001 |
Placental hypofunction | 30 (14.0%) | 554 (11.5%) | 22 (8.6%) | 0.177 |
Preeclampsia | 29 (13.6%)** | 118 (2.4%) | 7 (2.7%) | < 0.001 |
Mild preeclampsia | 12 (5.6%)** | 81 (1.7%) | 7 (2.7%) | < 0.001 |
Serious preeclampsia | 17 (7.9%)** | 37 (0.8%) | 0 (0%) | < 0.001 |
Intrahepatic cholestasis during pregnancy | 8 (3.7%) | 79 (1.6%) | 2 (0.8%) | 0.076 |
Thyroid dysfunction | 11 (5.1%) | 411 (8.5%) | 23 (9%) | 0.368 |
Virus infection | ||||
HBV | 5 (2.3%) | 111 (2.3%) | 6 (2.3%) | 0.998 |
Syphilis | 1 (0.5%) | 26 (0.5%) | 1 (0.4%) | 0.943 |
HPV | 0 (0%) | 12 (0.2%) | 1 (0.4%) | 0.688 |
Abnormal shape of placenta | 19 (8.9%) | 343 (7.1%) | 18 (7.0%) | 0.678 |
Pelvic adhesion | 3 (1.4%) | 97 (2.0%) | 6 (2.3%) | 0.761 |
Anemia | 18 (8.4%) | 562 (11.6%) | 40 (15.6%) | 0.048 |